DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Taplitumomab paptox
Taplitumomab paptox
Modifications to the Harmonized Tariff Schedule of the United States To
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
I Regulations
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
EP3027208T3.Pdf
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Methods and Compositions for Prediction of Therapeutic Efficacy of Cancer Treatments and Cancer Prognosis Upon Antibody Treatment
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Top View
Fig. 2 O W O 2012/149282 A2 1Inn Iiiiiii 1Mil I Mil Il I 1Ill I Mil I Il I I Mill Mi I I
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
(12) United States Patent (10) Patent No.: US 9,345,770 B2 Storkus Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Engineered Fc Regions for Site-Specific Conjugation
Customs Tariff - Schedule
"The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
(INN) for Biological and Biotechnological Substances
Dihydropyrrolidino-Pyrimidines As Kinase Inhibitors Dihydropyrrolidinpyrimidine Als Kinaseinhibitoren Dihydropyrrolidinopyrimidines Comme Inhibiteurs De Kinase
Ep 3088005 A1
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al